Accurate test results for key emerging and neglected infectious diseases:
Introducing EndomTest™
The first in vitro diagnostic test for endometriosis based on a patient’s blood sample.
At Kephera, we are developing point-of-care and ELISA immunoassays to aid in the diagnosis of infectious diseases impacting millions of people globally.
Framingham, MA – February 10, 2026. Kephera Diagnostics has launched the first commercial testing panel for liver fluke infection, offered through its CLIA laboratory, the Company announced today. The panel includes tests for three liver fluke species, Clonorchis sinensis (Chinese...
Single-tier test showed >90% sensitivity in early Lyme disease patients Framingham, MA – August 20, 2025 A new serologic test for Lyme disease shows promise to streamline the testing protocol and to enable the diagnosis of patients in very early...
Framingham, MA – July 24, 2025 Kephera Diagnostics, a CLIA-certified and CAP-accredited diagnostic laboratory, announced the launch today of EndomTest™, the first non-invasive commercially available diagnostic test for endometriosis in the United States. This innovative test only requires a blood...
Framingham, MA – April 30, 2024. Kephera Diagnostics has been awarded a two-year, $606,498 grant from the National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health (NIH), the company announced today. The grant,...
Framingham, MA- April 12, 2024. As World Chagas Day approaches on April 14th, Kephera Diagnostics is excited to announce the addition of a third serological test for Chagas disease, the TESA immunoblot, to its CLIA-certified, CAP-accredited clinical laboratory test menu....
Framingham, MA – June 5, 2023. Kephera Diagnostics announced today the launch of CLIA laboratory tests for Chagas disease, neurocysticercosis, and liver fluke infection, which add to its existing CLIA tests for Lyme disease. For Chagas disease, Kephera will offer...
This site uses cookies. By continuing to browse the site, you are agreeing to our use of cookies.
DismissWe may request cookies to be set on your device. We use cookies to let us know when you visit our websites, how you interact with us, to enrich your user experience, and to customize your relationship with our website.
Click on the different category headings to find out more. You can also change some of your preferences. Note that blocking some types of cookies may impact your experience on our websites and the services we are able to offer.
These cookies are strictly necessary to provide you with services available through our website and to use some of its features.
Because these cookies are strictly necessary to deliver the website, refusing them will have impact how our site functions. You always can block or delete cookies by changing your browser settings and force blocking all cookies on this website. But this will always prompt you to accept/refuse cookies when revisiting our site.
We fully respect if you want to refuse cookies but to avoid asking you again and again kindly allow us to store a cookie for that. You are free to opt out any time or opt in for other cookies to get a better experience. If you refuse cookies we will remove all set cookies in our domain.
We provide you with a list of stored cookies on your computer in our domain so you can check what we stored. Due to security reasons we are not able to show or modify cookies from other domains. You can check these in your browser security settings.
We also use different external services like Google Webfonts, Google Maps, and external Video providers. Since these providers may collect personal data like your IP address we allow you to block them here. Please be aware that this might heavily reduce the functionality and appearance of our site. Changes will take effect once you reload the page.
Google Webfont Settings:
Google Map Settings:
Google reCaptcha Settings:
Vimeo and Youtube video embeds:
You can read about our cookies and privacy settings in detail on our Privacy Policy Page.
Privacy Policy